| November 9, 2008 | ||||||||||||
| Room | Lisbon 2004 | Sidney 2000 | San Francisco 1996 | Nice 1992 | Kyoto 1988 | Quebec 1984 | Melbourne 1980 | Hamburg 1976 | Washington DC 1972 | Mexico City 1968 | London 1964 | Copenhagen 1960 |
| 08:15 08:50 |
Plenary Lecture Human Population Growth and Global Warming: the sky is the limit Roger Short (AU) Chairs: Shlomo Melmed / Amélio Godoy Matos |
|||||||||||
| 08:50 09:25 |
Plenary Lecture Worldwide view of thyroid cancer Rui Maciel (BR) Chairs: Shlomo Melmed / Amélio Godoy Matos |
|||||||||||
| 09:30 11:00 |
Symposium Adrenal | Panels | Symposium Bone and Ageing |
Symposium Diabetes | Symposium Diabetes | Symposium Reproductive Endocrinology and Inhibin-Activin | Symposium Pituitary, growth hormone, IGFs and neuroendocrinology | Symposium hormone action, nuclear and membrane signalling | Symposium Gene Expression & regulation | Oral Communication 1 | Oral Communication 2 | |
| Cushing's Syndrome (Clinical) Chair: Lynette Nieman (USA); Mauro Czepielewski (BR) 1. The molecular basis of corticotroph development and disease Thierry Brue (FR) 2. Diagnosis of Cushing' Syndrome John Newell Price (UK) 3. Nelson's Syndrome Guillaume Assié (FR) |
Thyroid Cancer - issues in primary treatment and monitoring Chair: James Fagin (USA) R. Michael Tuttle (USA) Petros Perros (UK) Ian Hay (USA) |
Bone resorption control and new therapeutic strategies
(Translational) Chair:Lance Lanyon (UK); João Lindolfo Borges (BR) 1. Regulation of RANK ligand production and its signalling in osteoclast formation Noboyuki Udagawa (JP) 2. Anti-RANKL treatment in osteoporosis and skeletal complications of cancer Lorenz Hofbauer (DE) 3. Combining anti-resorptive with anabolic treatments for osteoporosis Robert Neer (USA) |
Mytochondria and Diabetes (Basic) Chair: Ernesto Bernal-Mizrachi (USA), Adriana Lofrano (BR) 1. Mitochondrial metabolism in pancreatic ß-cells: implications for Type 2 Diabetes Hindrik Mulder (SE) 2. UCP2 as a therapeutic target for the treatment of diabetes Chen-Yu Zhang (CN) 3. The role of mTOR in the beta-cell adaptation to hyperglycemia and oxidative stress in Type 2 diabetes Gil Leibowitz (IL) |
What works for diabetes and obesity prevention
in a public health setting (Translational) Chair: Walmir Coutinho (BR); Marcio Mancini (BR) 1. Policy and National Strategy Walmir Coutinho (BR) 2. Role of the Food Industry in the Prevention of Obesity Mark Pirner (USA) 3. Lifestlye intervention to reduce diabetes and beyond - the Chinese experience GW Li (CN) |
Menopause and HRT (Clinical) Chair: Lisa Moran (AU), Ricardo Meirelles (BR) 1. Menopausal transition John F. Randolph (USA) 2. Phytoestrogens and cardiovascular disease in the menopause Helena Teede (AU) 3. Phytoestrogens and climacteric complaints, the bone and the cardiovascular system Wolfgang Wuttke (DE) |
Novel biomarkers in pituitary tumorigenesis (Basic) Chair: Michael Buchfelder (DE); Margaret Castro (BR) 1. GDNF/Ret as a survival signal in pituitary Clara V. Alvarez (SP) 2. Identifying new targets for pituitary tumor treatment Marily Theodoropoulou (DE) 3. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity Alfredo Fusco (IT) |
Signalling at the plasma membrane (Basic) Chair: Markus Stoffel (CH); Rodrigo Moreira (BR) 1. New regulatory pathways for LH receptor signalling by exon splicing Joerg Gromoll (DE) 2. Adiponectin signalling Toshi Yamauchi (JP) 3. Regulation of hepatic energy metabolism by insulin Wataru Ogawa (JP) |
Thyroid transcription factor disorders (Basic) Chair: Graham Williams (UK), Gisah Carvalho (BR) 1. Genes involved in thyroid morphogenesis and related disorders Roberto DiLauro (IT) 2. Genetic Disorders of the Pituitary-Thyroid Axix Krishna Chatterjee (UK) 3. Thyroid, lung and brain defects caused by TTF1 gene mutations Peter Kopp (USA) |
Endocrine Oncology Chair: Ben Glaser (USA) |
Paediatric Endocrinology 1 Chair: Berenice Mendonça (BR) |
||
| 11:00 11:45 |
Poster | |||||||||||
| 11:45 12:45 |
Debates The primary treatment of acromegaly is medical Chair: M. Mercado (MX) For: Michael Sheppard (UK) Against: Michael Buchfelder (DE) |
Meet the Professor (Clinical) Difficult cases of hyperlipidemia F. Raal (ZA) |
Meet the Professor (Clinical) Anabolic agents in osteoporosis Jack Martin (AU) |
Meet the Professor (Clinical) MEN 1 Guang Ning (CH) |
Meet the Professor (Clinical) Thyroid nodules Paolo Vitti (IT) |
Meet the Professor (Clinical) Inpatient diabetes management Marcia Nery (BR) |
Meet the Professor (Clinical) Glucocorticoid replacement therapy optimisation Anton Luger (AT) |
Meet the Professor (Clinical) Turner´s syndrome Claus H. Gravholt (DK) |
Meet the Professor (Basic) Proteomics/Metabolics Metabolic approaches for understanding of chronic disease mechanisms Christopher Newgard (USA) |
Meet the Professor (Basic) Immune tolerance and the use of stem cells in cell replacement: Road-map towards stem cell replacement therapy in diabetes Henrik Semb (SE) |
Meet the Professor (Basic) RNAi Highthtoughput genome wide RNAi screens in Drosophila cell based-assays and in vivo Norbert Perrimon (USA) |
|
| 13:00 14:30 |
Symposium Diabetes | Symposium Bone and Ageing |
Symposium Thyroid | Symposium Pediatrics | Symposium Reproductive Endocrinology and Inhibin-Activin | Symposium Pituitary, growth hormone, IGFs and neuroendocrinology | Symposium hormone action, nuclear and membrane signalling | Symposium Gene Expression & regulation | Oral Communication 3 | Oral Communication 4 | ||
| New Modalities for the Treatment Obesity and Diabetes
(Clinical) Chair: Guillermo Umpierrez (USA) ; Bruno Geloneze (BR) 1. Endocannabinoids and the Control of Energy Balance Uberto Pagotto (IT) 2. Gastrointestinal operations that eliminate diabetes: Mechanisms and prospects David E. Cummings (USA) 3. Drug therapy in obesity and diabetes: reconciliating the new and the old Pablo Aschner (CO) |
Building bones: current and coming anabolic agents
(Translational) Chair: David Goltzman (CA); Paulo Lacativa (BR) 1. How PTH builds bone Gary Krishnan (USA) 2. Discovery and biology of the SOST gene Wim Van Hul (BE) 3. Anti-sclerostin as an anabolic therapy for bone Xiaodong Li (USA) |
Insights on thyroid disease pathogenesis from basic
science (translational) Chair: David Cooper (USA); Valéria Guimarães (BR) 1. Bile acids as metabolic integrators through modulation of thyroid hormone metabolism Antonio C. Bianco (USA) 2. Transcriptome of thyroid cancer and its relation to disease characteristics Barbara Jarzab (PL) 3. Biological effects of thyroid hormone on bone Graham Williams (UK) |
Hyperandrogenic syndromes (Clinical) Chair: Annette Grüters (DE); Margaret Boguszewski (BR) 1. Polycystic ovary syndrome: a disease from adolescence to adulthood Fahrettin Kelestimur (TR) 2. Aromatase deficiency: from molecular diagnosis to clinical manifestations Alicia Belgorosky (AR) 3. Longitudinal insulin dynamics and steroid hormone flux across puberty in girls at high risk for PCOS David Geller (USA) |
New frontiers in Activin and Inhibin Function (Basic) Chair: Axel Themmen (NL); Poli Mara Spritzer (BR) 1. Activin regulation of gonadotropin synthesis Daniel J. Bernard (CA) 2. Regulation of adipocyte activin during weight loss Lena Carlsson (SE) 3. Regulation of Inhibin Subunit Gene Expression Kelly Mayo (USA) |
Regulation of hypothalamic-pituitary crosstalk
(Translational) Chair: Carlos Diequez (ES), Julio Abucham Filho (BR) 1. Alterations in metabolism induced by sleep loss Karine Spiegel (FR) 2. Novel approaches in the treatment of hypothalamic obesity Robert Lustig (USA) 3. Adipokines as hypophysiotropic factors Maria Del Mar Malagon (SP) |
The Expanding Role of the Mineralocorticoid Receptor
(Basic) Chair: Kevin Docherty (UK), Claudio Kater (BR) 1. Mineralocorticoids in the heart John Funder (AU) 2. The pivotal role of the mineralocorticoid receptor in adipogenesis Maria-Christina Zennaro (FR) 3. Mineralocorticoid receptor activation and vascular remodelling and disease Iris Jaffe (USA) |
Role of Coactivators and Corepressors in Metabolism
(Basic) Chair: Vincent Giguere (CA), José Antonio Marcondes (BR) 1. Diverse Actions of RIP140 in Metabolic Regulation Malcolm Parker (UK) 2. Transcriptional control of mitochondrial function by PGC-1 coactivators Daniel Kelly (USA) 3. The role of ERRs in energy homeostasis Anastasia Kralli (USA) |
Ageing & Thyroid Oncology Chair: Petros Perros (UK) |
Female Reproductive Endocrinology 1 Chair: Axel Themmen (NL) |
|||
| 14:35 15:10 |
Plenary Lecture Roles of the CRF/Urocortin family and their receptors in stress and metabolism Wylie Vale (USA) Chairs: J. Larry Jameson / Jérôme Bertherat |
2:00pm - 6:00 pm Conselho Deliberativo da SBEM |
||||||||||
| 15:10 15:45 |
Plenary Lecture The discovery of novel bioactive peptides, lessons from animals for endocrinology Hubert Vaudry (FR) Chairs: J. Larry Jameson / Jérôme Bertherat |
|||||||||||
| 15:45 | Break | |||||||||||
| 16:00 | Satellite Symposium Sanofi-Aventis | Satellite Symposium AstraZeneca AB | Satellite Symposium Pfizer | Satellite Symposium Servier |
||||||||
| November 10, 2008 | ||||||||||||
| Room | Lisbon 2004 | Sidney 2000 | San Francisco 1996 | Nice 1992 | Kyoto 1988 | Quebec 1984 | Melbourne 1980 | Hamburg 1976 | Washington DC 1972 | Mexico City 1968 | London 1964 | Copenhagen 1960 |
| 08:15 08:50 |
Plenary Lecture A global view of obesity - what should the political responses be? Barry Popkin (USA) Chairs: John Wass / Teresa Woodruff |
|||||||||||
| 08:50 09:25 |
Plenary Lecture Genetics of Complex Disease: Thinking big: understanding the genetic basis of diabetes, obesity and stature Mark McCarthy (UK) Chairs: John Wass / Teresa Woodruff |
|||||||||||
| 09:30 11:00 |
Symposium Thyroid | Panels | Symposium Pediatrics | Symposium Bone and Ageing |
Symposium Diabetes | Symposium Adrenal | Symposium Reproductive Endocrinology and Inhibin-Activin | Symposium Pituitary, growth hormone, IGFs and neuroendocrinology | Symposium Gene Expression & regulation | Oral Communication 5 | Oral Communication 6 | |
| Thyroid: New developments in thyroid cancer Chair: Ian Hay (USA); Mario Vaisman (BR) 1. Diagnostic Markers of Thyroid cancer, can we avoid unnecessary surgery? Janete Cerutti (BR) 2. New insight in familial non-medullary thyroid carcinoma Furio Pacini (IT) 3. Targeted therapies in thyroid cancer: Results of early clinical trials Steven I. Sherman (USA) |
Osteoporosis - treatment monitoring and how long
for? Chair: John Bilezikian (USA); Sokratis Papapoulos (NL) Dolores Pardini (BR) Ian Reid (NZ) |
Strategies to enhance final height in children with idiopathic short stature (Clinical) Chair: Martin Savage (UK); Paulo Solberg (BR) 1. Dissecting 'idiopathic' short stature before GH therapy Ze'ev Hochberg (IL) 2. GH + aromatase inhibitors Leo Dunkel (FI) 3. GH + GnRH Fernando Cassorla (CL) |
Endocrinology and paracrinology of bone: who is
in charge? (Basic) Chair: Jack Martin (AU); Paulo Lacativa (BR) 1.T. cells: unexpected players in the mechanism of action of estrogen and PTH in bone Robert Pacifici (USA) 2. Endocrinology/Paracrinology in Bone: Parathyroid Hormone , Parathyroid Hormone Related Peptide and Vitamin D Relationships David Goltzman (Ca) 3. Estrogen Receptor? is a key contributor to the mechanical regulation of bone Lance Lanyon (UK) |
Inpatient management of the diabetic patient (Clinical) Chair: Dinky Levitt (SA), Marcos Tambascia (BR) 1. Does Hyperglycaemia Impact inpatient outcome? Silmara Leite (BR) 2. Management of Inpatient Hyperglycemia: Facts or Fiction Guillermo Umpierrez (USA) 3. Glycemic control in the intensive care unit: Are we making a difference? Greet Van den Berghe (BE) |
Adrenocortical development (Basic) Chair: Wiebke Arlt (UK), Romolo Sandrini (BR) 1. Transcriptional regulation of adrenal stem cell development Gary Hammer (USA) 2. An adrenocortical enhancer regulates developmental expression of steroidogenic factor 1 Ken-Ichirou Morohashi (JP) 3. Zebrafish models of adrenal development Bon-chu Chung (TW) |
New aspects in sex differentiation (Basic) Chair: Deborah Bourc'his (FR); Elaine Maria Frade Costa (BR) 1. Signalling at the Crossroads of Development Blanche Capel (USA) 2. New genes and mechanisms for sex development Tsutoma Ogata (JP) 3. Identification of a new candidate inclued in sex determination Dagmar Wilhelm (AU) |
Understanding hypopituitarism (Translational) Chair: Felipe Casanueva (ES); Nina Mussolino (BR) 1. Animal models of adult-onset GH-deficiency Rhonda D. Kineman (USA) 2. Hypopituitarism after brain damage: Clinical relevance and practice guidelines Amar Agha (IRE) 3. New concepts in hormone replacement therapy Georg Brabant (UK) |
Transcriptional regulation by PPARs (or orphan
nuclear receptors) (Basic) Chair: Keith Parker (USA), Carmen C. Pazos de Moura (BR) 1. Regulation of lipid metabolism and immunity by orphan nuclear receptors Peter Tontonoz (USA) 2. PPAR Signaling in Macrophage Activation and Obesity Ajay Chawla (USA) 3. Macrophage Arginasis: Molecular Targets of nuclear receptor signaling Ines Corraliza (ES) |
Diabetes 1 Chair: Daniel Drucker (CA) |
Gene Regulation / Membrane and Nuclear Receptors/Signalling Chair: Justo Castano (ES) |
||
| 11:00 11:45 |
Poster | |||||||||||
| 11:45 12:45 |
Debates Androgen therapy should be offered to postmenopausal women with low libido Chair: Karen Miller (USA) For: Glenn Braunstein (USA) Against: William Rosner |
Meet the Professor (Clinical) Mineralocorticoid hypertension - investigation Claudio Kater (BR) |
Meet the Professor (Clinical) Paget´s disease - management Peter Selby (UK) |
Meet the Professor (Clinical) Management of craniopharyngioma Niki Karavitaki (UK) |
Meet the Professor (Clinical) Management of Hypopituitarism Vera Popovic (SP) |
Meet the Professor (Clinical) Management of congenital hypothyroidism Guy van Vliet (CA) |
Meet the Professor (Clinical) New agents in management of type 2 diabetes Jaime Davidson (USA) |
Meet the Professor (Clinical) Ambiguous genitalia Marco Rivarola (AR) |
Meet the Professor (Basic) Genes, diabetes and obesity Mark McCarthy (UK) |
Meet the Professor (Basic) Manipulating the Mouse Genome Genetically modified mouse models: advanced tools for studyng endocrinology Rachel Davey (AU) |
||
| 13:00 14:30 |
Symposium Diabetes | Panels | Symposium Thyroid | Symposium Bone and Ageing |
Symposium Diabetes | Symposium Pituitary, growth hormone, IGFs and neuroendocrinology | Symposium Reproductive Endocrinology and Inhibin-Activin | Symposium Adrenal | Symposium Gene Expression & regulation | Oral Communication 7 | Oral Communication 8 | ISGE Special Symposium |
| Diabetes - Major outcome studies (Clinical) Chair: Ruy Lyra (BR), Adriana Costa e Forti (BR) 1. What have we learned from recent clinical trials? Steve Kahn (USA) 2. Making Sense of Conflicting Results Steve Colagiuri (AU) 3. Critical re-evaluation of therapy guidelines Marcos Tambascia (BR) |
Pediatric to Adult Transition - how and when? Chair: Helena Gleeson (UK) A Grueters (DE) Hugo Fideleff (AR) Cesar Boguszewski (BR) |
Oncogenic Kinases in thyroid cancer (Basic) Chair: Clara V. Alvarez (ES); Vania M. Costa (BR) 1. Kinase signalling and their disruption in thyroid cancer Minho Shong (SK) 2. Targeting RET kinases in thyroid cancer Massimo Santoro (IT) 3. Mouse models of PI3 kinases in thyroid cancer Antonio di Cristofano (USA) |
Therapies for osteoporosis (Clinical) Chair:Gary Krishnan (USA), Luiz A. Russo (BR) 1. Absolute fracture risk and changing burden of disease internationally Kassim Javaid (UK) 2. What can be achieved with anti-resorptive drugs? Peter Ebeling (AU) 3. Treatment - why, whom, when, what drug, and for how long? Michael McClung (USA) |
Life and Death of the Beta-cell (Basic) Chair: Benjamin Glaser (USA); Licio Veloso (BR) 1. Regulation of cell cycle and control of beta-cell mass Ernesto Bernal-Mizrachi (USA) 2. Role of NK-kB in beta-cell death in models of Type I Diabetes Mellitus Danielle Melloul (IL) 3. Animal models of beta-cell regeneration Ahmed Mansouri (DE) |
GH in adults (Clinical) Chair: John Newell-Price (UK); Monica Gadelha (BR) 1. GH deficiency in adults Jens S. Christiansen (DK) 2. New views of Quality-of-Life Testing in GH deficiency Susan Webb (ES) 3. GH treatment for the frail elderly Andrew R. Hoffman (US) |
Anti-Mullerian Hormone (AMH): an expanding tool
in Reproductive Endocrinology and Oncology (Translational) Chair: Kelly Mayo (USA); Marisa Breitenbach (BR) 1. AMH in disorders of gonadal function in infancy and childhood Rodolfo Rey (AR) 2. Ovarian AMH production: Implications for the diagnosis of ovarian reserve Axel Themmen (NL) 3. MIS as a therapeutic agent David MacLaughlin (USA) |
Phaeochromocytoma (Clinical) Chair: Karel Pacak (USA); Lucio Vilar (BR) 1. Genetics of phaeocromocytoma in Chinese patients Zhengpei Zeng (CN) 2. What is the optimal roadmap to the diagnosis of phaeochromocytoma? Jacques Lenders (NL) 3. Perioperative management of phaeochromocytoma Hartmut Neumann (DE) |
Androgen receptor regulated transcription (Basic) Chair: Rob McLaughlan (AU), Adelina Marta dos Reis (BR) 1. Androgen receptor on chromatin Ollie Janne (FI) 2. Regulation of AR activity by FOX gene family Toshihiko Yanase (JP) 3. Epigenetic Regulation of Androgen receptor-mediated Transcription Sung Hee Baek (KR) |
Cardiovascular Endocrinology/Hypertension Chair: Paul Stewart (UK) |
Calcium & Bone Chair: Jack Martin (AU) |
Gynecological Endocrinology: New insights from
molecular biology Chair: Evan Simpson 1. The meyer-Rokitanski-Kuster-Houser Syndrome: new molecular genetic development Charles Sultan (AU) 2. Polimorphism of Endocanabinoid Receptor and Metabolic Profile in Postmenopausal Women Andrzej Milewicz 3. Sex, fat and breast cancer Evan Simpson 4. The Immune system, brain and menopause Ivaldo Silva |
|
| 14:35 15:10 |
Plenary Lecture Neuroendocrine control of energy and metabolism: role of the products of the ghrelin gene Ezio Ghigo (IT) Chairs: Masatomo Mori / Enio Martino |
|||||||||||
| 15:10 15:45 |
Plenary Lecture The adipocyte as an endocrine organ Yuji Matsuzawa (JP) Chairs: Masatomo Mori / Enio Martino |
|||||||||||
| 15:45 | Break | |||||||||||
| 16:00 | Satellite Symposium Merck-Serono | Satellite Symposium Eli Lilly | Satellite Symposium Bayer | Satellite Symposium Novartis | Satellite Symposium Novo Nordisk | ISE General Council Meeting (Starting 5:00pm) | ||||||
| November 11, 2008 | ||||||||||||
| Room | Lisbon 2004 | Sidney 2000 | San Francisco 1996 | Nice 1992 | Kyoto 1988 | Quebec 1984 | Melbourne 1980 | Hamburg 1976 | Washington DC 1972 | Mexico City 1968 | London 1964 | Copenhagen 1960 |
| 08:15 08:50 |
Plenary Lecture The use of stem cells in endocrinology David Tosh (UK) Chairs: Paul Stewart / Justo Castano |
|||||||||||
| 08:50 09:25 |
Plenary Lecture New insights into nuclear receptors - implications for endocrinology Ana Aranda (ES) Chairs: Paul Stewart / Justo Castano |
|||||||||||
| 09:30 11:00 |
Symposium Adrenal | Panels | Symposium Thyroid | Symposium Bone and Ageing |
Symposium Diabetes | Symposium Pediatrics | Symposium Reproductive Endocrinology and Inhibin-Activin | Symp | ||||